Fosmanogepix treatment for coccidioidomycosis under an expanded access program

By afschroeder • April 22, 2026

Cohen SH, Allyn P, Chow FC, Rathe J, Nanayakkara DD, Hutfles G, Vijayan T, Smith EA, Saling CF, Ilges D, Schlamm HT, Thompson GR 3rd. Fosmanogepix treatment for coccidioidomycosis under an expanded access program. Clin Infect Dis. 2026 Apr 21:ciag271. doi: 10.1093/cid/ciag271. Epub ahead of print. PMID: 42015519.

Tags: antifungal, Coccidioidomycosis, expanded access program, fosmanogepix, Infectious Diseases, Publications

Generative artificial intelligence for surgical site infection surveillance

Alshanqeeti S, de Guzman A, Riley MK, Coffey KC, Goodman KE, Harris AD, Baghdadi J, Pineles L, Branch-Elliman W, Morgan DJ. Generative artificial intelligence for[...]

Electronic Clinical Quality Measures of Antibiotic Use in Hospitalized Adults with Uncomplicated Community-acquired Pneumonia

White AT, Goetz MB, Jones M, Neuhauser MM, Ciarkowski C, Ratz D, Gupta A, Petty LA, Gandhi TN, Zhang M, Kent B, Wu C, Horowitz[...]

Community PrEP delivery preferences among pregnant and breastfeeding women using oral PrEP in south africa and kenya

Wara NJ, Mvududu R, Marwa MM, Gómez L, Mashele N, Orrell C, Kinuthia J, John-Stewart G, Myer L, Hoffman R, Pintye J, Davey DLJ. Community[...]